Cargando…
Hypocomplementemia during tocilizumab treatment: Long-term follow-up results
Hypocomplementemia has been reported in patients with rheumatoid arthritis treated with tocilizumab (TCZ), but its long-term consequences are unknown. We assessed the long-term outcome of patients treated with TCZ who developed hypocomplementemia regarding serious bacterial infections or autoimmune...
Autores principales: | Bieber, Amir, Markovits, Doron, Toledano, Kohava, Tavor, Yonit, Mader, Reuven, Balbir-Gurman, Alexandra, Braun-Moscovici, Yolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276208/ https://www.ncbi.nlm.nih.gov/pubmed/35713462 http://dx.doi.org/10.1097/MD.0000000000029528 |
Ejemplares similares
-
Large leg ulcers due to autoimmune diseases
por: Rozin, Alexander P., et al.
Publicado: (2011) -
Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis
por: Fukui, Shoichi, et al.
Publicado: (2016) -
Ultrasound Investigation of the Glenohumeral Joint by Anterior Access in Patients with Rheumatoid Arthritis and Healthy Controls
por: Rozin, Alexander P., et al.
Publicado: (2015) -
Longitudinally Extensive Transverse Myelitis in a Lupus–Neuromyelitis Optica Overlap
por: Tavor, Yonit, et al.
Publicado: (2021) -
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020)